A dire warning has been issued by an MP in London: ending the emergency care pilot for sickle cell patients could have fatal consequences. This pilot program, known as the Same Day Emergency Care (SDEC) unit, operated at the Royal London Hospital in Whitechapel from September 2025 to January, offering an alternative to the traditional A&E admissions for sickle cell patients.
Abi Osei-Mensah, a sickle cell campaigner and frequent visitor to the unit during the pilot, expressed disappointment at the removal of such an effective service. Barts Health NHS Trust acknowledged the support for the pilot and assured patients of continued specialist care at their Haematology Day Unit. However, the trust's decision to end the pilot has sparked controversy and concerns.
Sickle cell disease, the most common and rapidly growing genetic condition in the UK, predominantly affects people of Black African or Caribbean descent. London has the highest number of individuals living with sickle cell, according to the Haemoglobinopathy Registry. This blood disorder requires lifelong management of extremely painful episodes known as sickle cell crises, often necessitating hospital admission and powerful painkillers.
Labour MP Bell Ribeiro-Addy emphasized the potential fatal outcome of ending the emergency care pilot, urging the government to develop a national strategy for specialized sickle cell care. A petition against the pilot closure highlighted the unit's importance, providing quick and compassionate treatment for acute pain crises often mismanaged in standard A&E settings.
Barts Trust has stated that sickle cell patients will now have to use their A&E department for emergency care, but they assure that specialist-led care will continue at the hospital's Haematology Day Unit. However, sickle cell patients like Osei-Mensah and Delo Biye, who regularly traveled over 10 miles to access the emergency unit, are concerned about the change. Osei-Mensah, who actively avoids A&E due to previous unbearable experiences, emphasizes that just being in A&E can worsen a sickle cell crisis.
National guidelines from the National Institute for Health and Care Excellence (NICE) advise treating a sickle cell crisis as an acute medical emergency, with patients receiving pain relief within 30 minutes of arriving at the hospital. Osei-Mensah's experiences in A&E, including waiting longer than 30 minutes just to be triaged, highlight the challenges faced by sickle cell patients. The emergency unit pilot offered faster pain relief, but there were communication issues, with many patients unaware of the unit's existence.
Delo Biye, who described the emergency unit as a haven and a place of safety during painful crises, believes the pilot's short duration was a tease for the sickle cell community. After the pilot ended, he spent 24 hours in A&E during a sickle cell crisis, ultimately giving up hope of admission and returning home. Ribeiro-Addy, MP for Clapham and Brixton Hill, called attention to the trial closure, stating it was typical of the wider trends in sickle cell care, where the necessary level of support is often lacking.
Ribeiro-Addy and Labour MP Apsana Begum, whose constituents in Poplar and Limehouse used the emergency unit, are advocating for the reinstatement of the pilot and the rollout of more emergency units across London. They believe that the government should commit to a national strategy, as the shutting down of such units can significantly impact the well-being and safety of individuals living with sickle cell disease. The blueprint for better treatment already exists in the recommendations of the 'No One's Listening' report, published in 2021 by the All Party Parliamentary Group for Sickle Cell and Thalassaemia and the Sickle Cell Society. This report highlighted the sub-standard care, stigmatization, and lack of prioritization faced by sickle cell patients.
The controversy surrounding the ending of this emergency care pilot raises important questions about the accessibility and quality of healthcare for individuals living with sickle cell disease. It prompts us to consider whether the current system is adequately meeting the needs of this vulnerable community. What are your thoughts on this matter? Do you believe that specialized care for sickle cell patients should be a priority, and if so, how can we ensure that such services are sustained and expanded?
